IRVINE, Calif., Sept. 5, 2014 (GLOBE NEWSWIRE) -- Praxsyn Corporation (OTCQB:PXYN), a medication and service provider for medical practitioners, announced that it has received approval from the Financial Industry Regulatory Authority ("FINRA") for an official change in the name of the Company effective at the open of business on September 5, 2014. As previously announced, the Company changed its name to Praxsyn Corporation and will now trade under the symbol "PXYN".
"The name has been changed to reflect the Company's current business of pharmaceutical services, and is no longer affiliated with pet services," said Edward F. Kurtz, Chief Operating Officer, Praxsyn Corporation.
At Praxsyn, headquartered in Irvine, California, we work to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, our wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.
CONTACT: Media/Investor Contact: IR@PraXsyn.com 949-777-6112 ext 101